Back to Results
First PageMeta Content
Piperazines / Pharmaceutical industry / Food and Drug Administration / United States Public Health Service / New Drug Application / Biosimilar / Food and Drug Administration Amendments Act / Moxifloxacin / Pharmacology / Pharmaceutical sciences / Clinical research


Microsoft Word - FINAL 2012 Peds ODAC briefing document[removed]doc
Add to Reading List

Open Document

File Size: 99,52 KB

Share Result on Facebook

Company

Amgen Inc. / Boehringer Ingelheim Pharmaceuticals Inc. / Threshold Pharmaceuticals Inc. / Trametinib COMPANY / GlaxoSmithKline LLC / /

Event

FDA Phase / /

IndustryTerm

biological products / products / therapies for pediatric rare diseases / treatment of pediatric cancers / biologic products / /

MedicalCondition

BRAF V600-mutant melanoma / rare diseases / papillary thyroid cancer / differentiated thyroid cancer / Langerhans cell histiocytosis / myelodysplastic syndrome / metastatic soft tissue sarcomas / pediatric acute lymphoblastic leukemia / original rare disease / glioma / V600-mutant metastatic melanoma / neuroblastoma / rare pediatric disease / melanoma / non-small cell lung cancer / juvenile pilocytic astrocytoma / pediatric rare disease / recurrent solid tumors / pediatric rare diseases / pancreatic cancer / specific diseases / cancer / neuroblastoma and neurofibromatosis-related tumors / tumors / disease / malignant peripheral nerve sheath tumors / pediatric melanoma / recurrent/refractory cancer / rare disease / myeloid leukemias / soft tissue sarcoma / optic glioma / Therefore pediatric tumors / triple negative breast cancer / sarcomas / pediatric cancers / several pediatric cancers / several other adult tumor / pediatric gliomas / metastatic melanoma / /

Organization

office of Hematology and Oncology Products / Food and Drug Administration / Congress / Review Committee / Review Division / DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring / Oncologic Drugs Advisory Committee / FDA Briefing Document Pediatric Oncology Subcommittee / Advisory Committee / Pediatric Oncology Subcommittee / /

Person

Silver Spring / Richard Pazdur / /

Position

investigator / Director / /

Product

CR-406 / Act / V600 / /

ProvinceOrState

Maryland / /

Technology

simulation / drug development / /

URL

http /

SocialTag